The oncogenic role of the ETS transcription factors MEF and ERG

Cell Cycle

Volumn 9, Issue 17, 2010, Pages 3457-3459

  Sashida, Goro ^a   Bazzoli, Elena ^a   Menendez, Silvia ^a   Liu, Yan ^a   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

AML; AML1 ETO; MDM2; p53; Prostate cancer; Ras

Indexed keywords

MYELOID ELF1 LIKE FACTOR; PROTEIN P16; PROTEIN P53; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; ETS RELATED GENE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; LYMPHOMA; MALIGNANT TRANSFORMATION; MUTAGENESIS; ONCOGENE; ONCOGENE H RAS; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SARCOMA;

EID: 77956407339     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.17.13000     Document Type: Review

References (19)

1. Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 1996; 13:1721-9. (Pubitemid 26377504)
2. Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 2002; 17:437-49. (Pubitemid 35223533)
3. Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003; 31:342-50.
4. Moore SD, Offor O, Ferry JA, Amrein PC, Morton CC, Dal Cin P. ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25-26;q22). Leuk Res 2006; 30:1037-42. (Pubitemid 43831175)
5. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, et al. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 2002; 32:160-5. (Pubitemid 34977212)
6. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002; 32:153-9. (Pubitemid 34977211)
7. Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood 2005; 106:2498-505. (Pubitemid 41510825)
8. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-8. (Pubitemid 41528150)
9. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008; 8:497-511.
10. Zong Y, Xin L, Goldstein AS, Lawson DA, Teitell MA, Witte ON. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci USA 2009; 106:12465-70.
11. Marcucci G, Baldus CD, Ruppert AS, Radmacher MD, Mrozek K, Whitman SP, et al. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol 2005; 23:9234-42.
12. Loughran SJ, Kruse EA, Hacking DF, de Graaf CA, Hyland CD, Willson TA, et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol 2008; 9:810-9.
13. Stankiewicz MJ, Crispino JD. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood 2009; 113:3337-47.
14. Pereira DS, Dorrell C, Ito CY, Gan OI, Murdoch B, Rao VN, et al. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci USA 1998; 95:8239-44. (Pubitemid 28326097)
15. Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 4:37-48.
16. Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, et al. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene 2007; 26:4032-7. (Pubitemid 46884297)
17. Sashida G, Liu Y, Elf S, Miyata Y, Ohyashiki K, Izumi M, et al. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation. Mol Cell Biol 2009; 29:3687-99.
18. Fukushima T, Miyazaki Y, Tsushima H, Tsutsumi C, Taguchi J, Yoshida S, et al. The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases. Leuk Res 2003; 27:387-92. (Pubitemid 36287199)
19. Mao S, Frank RC, Zhang J, Miyazaki Y, Nimer SD. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol 1999; 19:3635-44.